Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
ranked as world leading or internationally excellent, and benefit from state-of-the-art high performance computing facilities, mathematical training, and world-leading international collaborations
-
to pursue a doctoral degree (Ph.D.). Remuneration is 100% TVL E13 according to the German public sector rates. CCBE's interdisciplinary team is performing research in the broad field of computational methods
-
industry. The center offers an excellent working environment with access to state-of-the-art technologies and an outstanding high-performance computing infrastructure. For TUD diversity is an essential
-
Deadline 14 Jan 2026 - 22:59 (UTC) Type of Contract Temporary Job Status Not Applicable Hours Per Week 40.0 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the
-
facilities and high-performance computing resources participation in international conferences, research stays, and collaborative networks collaboration with leading experts in imaging, modeling, and materials
-
. The selection committee consists of: Prof. dr. Mijke Houwerzijl, proposed supervisor Dr. Ane Aranguiz , proposed supervisor Prof. dr. Anne Lafarre, Research Program leader Dr. Inge Graef, Vice-Dean of Research
-
residues into higher alcohols —an innovative, sustainable alternative aligned with the UK’s Jet Zero and circular bioeconomy goals. Research Objectives The project aims to identify high-performing microbial
-
experience in software like Julia and Python is desirable. LanguagesENGLISHLevelExcellent Research FieldComputer scienceMathematics Additional Information Benefits Benefits A PhD programme of high quality
-
) on this 4-year position, you will be part of the research group “Quantum Information Science and Quantum Computation”, led by Univ.- Prof. Dr. Philip Walther. The group is part of the Quantum Optics, Quantum
-
neuronal network function and how recovery can be enhanced, with the eventual goal to translate findings to the clinic. We are currently developing a stable, long-term, high-throughput experimental system